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Objectives. The purpose of this study was to assess the extent
and reversibility of neuronal abnormalities in patients with an
acute myocardial Infarction.
Backgraard Previous experimental studies have described
isehemic injury to sympathetic neurons exceeding the area of
myocardial necrosis. Carbon-11 (C-11) hydroxyephedrine (HED)
is a norepinephrine analogue that can be used for the noninvasive
evaluation of neuronal integrity using positron emission toutogra-
phy
.
Methods. We studied 14 volunteers and 16 patients experienc-
ing a first acute myocardial infarction
. Positron emission tomo-
graphic imaging was used to quantitatively compare regional
perfusion, as assessed with nitrogen-13 ammonia, with myocardial
retention of C-11 hydroxyephedrine early after myocardial infarc-
tion as well as >6 months after the acute event .
Results
. C-11 hydroxyephedrioe and lbw images demonstrated
homogeneous tracer retention In volunteers but were abnormal In
all patients . Cdl hydroxyephedrine abnormalities were more
extensive than those for blood flow assessed by semiquantitative
polar map analysis (31 t 15% vs. 17 t 17% left ventricle; p <
Several radiolabeled catecholamine analogues are available
for scintigraphy to characterize the regional norepinephrine
storage capacity of presynaptic sympathetic nerve terminals
of the heart, including radioiodinated metaiodobenzylguani-
dine for single-photon emission computed tomography (1)
and C-I 1 hydroxyephedrine for positron emission tomogra-
phy (2) . C-I1 hydroxyephedrine has been developed as a
high specific activity positron-emitting tracer suitable for
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0.0$), particularly in five patients with non-Q wave infarction
(31 t 11% vs . 3.5 t 2.5% left ventricle; p = 0.008). Eleven
patients with Q wave Infarction had matched defects (28 t 17%
vs. 21 # 17% left ventricle; p = NS). C-11 hydroxyephedrine
tissue retention fraction was quantified in three t zones: zone
I (abnormal rest flow) had retention fraction 0 .037 t 0.022-`°h' ;
zone 2 (normal rest flow but decreased carbon-11 hydroxyephed-
rine retention) bad retention fraction 0 .068 t .034"R,, and zone
3 (normal flow and carbon-11 hydroxyephedrine retention) had
retention fraction 0 .087 t 0.041-"d " (p = 0.0004). Follow-up
studies at 8 t 3 months in eight patients revealed no change In
extent of abnormalities or absolute time tracer retention in
infarct and pert-infarct territories.
Conclusions. The results of abnormal regional sympathetic
innervation in patients with infarction confirm previous experi-
mental data and suggest persistent neuronal damage in infarct and
peri-infarct territories, without evidence of reinnervation of re-
versibly injured myocardium.
(J Am Coil Cardiof 1993;22:368-75)
both experimental and hum-1 studies. It has been validated
in our laboratory to be a highly specific marker for the
norepinephrine uptake-I and vesicular storage mechanisms
of the sympathetic nerve terminals (3). Previous studies in
our institution have demonstrated abnormal neuronal C-11
hydroxyephedrine retention in a number of settings, includ-
ing after cardiac transplant in humans (4,5) and in an animal
model of reperfused ischemic myocardial injury (6) .
Other investigators have demonstrated abnormal regional
myocardial ; :.- :ention of metaiodobenzylguanidine in areas of
neuronal injury induced by phenol application and also by
ischemia induced by coronary lawx injection (resulting in
transmural infarction) or ligation (nontransmural infarction),
with the extent of neuronal abnormality exceeding that for
abnormal blood flow in the infarct models (7-14). Such
regions have further been shown to demonstrate abnormal
refractoriness during electrophysiologic stimulation (15) .
Such findings could be important prognostically in hu-
mans after acute myocardial infarction because heterogene-
ity of cardiac sympathetic tone has been linked to postisch-
0735-10971931$6.00




C-I I HYDROXYEPHEDRINE PIN AFTER MYOCARDIAL INFARCTION
Figure 1 . Imaging protocol . After positioning in the tomograph, a
15-min transmission image was followed by a 740-MBq (20-mCi)
bolus injection of carbon-I I hydroxyephedrine (HED) with a 1-h
dynamic acquisition using 15 frames and then 740 MBq (20 mCi) of
nitrogen-13 ammonia or 1 .48 to 2.22 GBq (40 to 60 mCi) of
rubidium-82 was administered for 10-min static blood flow imaging .
emit arrhythmias and an increased incidence of sudden
death early after acute myocardial infarction (16-19) .
Therefore, to extend our investigation to humans, we
used C-I1 hydroxyephedrine with positron emission tomog-
raphy to allow quantitative assessment of neuronal injury .
We postulated that ischenuc neuronal injury in the human
heart after acute myocardial infarction exceeds the extent of
necrotic tissue and that this pattern could be potentially
reversible over time . We studied healthy volunteers as
control subjects and patients with a first acute myocardial
infarction within 7 ± 3 days using quantitative C-I l hydroxy-
ephedrLe and blood flow imaging and assessed the potential
reversibility of neuronal dysfunction with follow-up studies
in eight of these patients at 8 ± 3 months .
Methods
Patients. We studied 16 patients with a first acute myo-
cardial infarction and without evidence for noncoronary
heart disease or diabetes mellitus . Acute myocardial infarc-
tion was diagnosed on the basis of a combination at clinical
history, electrocardiographic (ECG) changes and elevation
in creatine kinase above normal range with abnormal MB
fraction. All patients received thrombolytic therapy with
intravenously administered recombinant tissue-type plas-
minogen activator (rt-PA), and four additionally had early
balloon coronary angioplasty to the infarct-related artery .
Patients studied while they were not taking drugs observed
to interfere with neuronal uptake of norepinephrine ana-
logues (20), including tricyclic antidepressants and amio-
darone. Other cardiac medications were continued as usual .
Positron emission ton agraphy . The study protocol was
approved by the Institutional Review Board of the Univer-
sity of Michigan Medical Center, and all patients gave
written informed consent to participate .
Initial positron emission tomography studies were per-
formed in all patients at 7 ± 3 days after myocardial
infarction, and follow-up studies obtained in eight patients
were performed at 8 ± 3 months . One patient died before a
follow-up study was performed, and the remaining patients
declined to participate in follow-up .
Studies were performed with a Siemens 931 15-slice
whole body tomograph. The imaging sequence is depicted
schematically in Figure 1. After placement of a 22-gauge
intravenous cannula in an antecubital vein and positioning in
OH
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Figure 2. Chemical structure of norepinephrine (left) and carbon-I I
hydroxyephedrine (right), produced by direct N-methylation of the
free base form of metaraminol .
the tomograph with the aid of a scout image, a 15-min trans-
mission study was acquired using a retractable germanium-68
ring source for subsequent attenuation correction of the
emission data . Neuronal imaging of the heart was performed
after bolus injection of 740 MBq (20 mCi) of C-I1 hydroxy-
ephedrine and a 1-h dynamic acquisition with 15 frames
(framing rates 6 X 30 s, 2 x 60 s, 2 x 150 s, 2 x 300 s, 2 x
600 s, I x 1,200 s). The chemical structure of C-1 l hydroxy-
ephedrine is shown in Figure 2 . After allowing I h for further
carbon-11 decay, a static 10-min myocardial blood flow
image was collected as a single-frame study . This was
performed to assess regional tracer delivery and to define the
extent of resting perfusion abnormalities . This image was
obtained either 60 s after injection of 1 .48 to 2.22 GBq (40 to
60 mCi) of rubidium-82 or 3 min after injection of 740 MBq
(20 mCi) of N-13 ammonia .
Data Analysis
Image reconstruction . The C-11 hydroxyephedrine and
blood flow emission data were attenuation corrected and
reconstructed by filtered backprojection using a Harming
filter with a cutoff of 0.3 cyclestpixel. Images were reori-
ented to the long and short axes of the left ventricle using a
SUN workstation (SUN Microsystems). A combined C-ll
hydroxyephedrine image of the 30- to 40-min postinjection
data was extracted from the dynamic sequence for visual
interpretation and generation of polar maps .
Homogeneity of relative myocardial tracer retention .
Polar maps of relative tracer activity were generated from
the short-axis blood flow and 30- to 40-nun C-11 hydroxy-
ephedrine images, using a ci -cumferential profile analysis
with a maximal search algorithm . A normal data base was
forrrid from the studies obtained in the 14 healthy volun-
teers for subsequent polar map analysis. The regional homo-
geneity of blood flow and C-11 hydroxyephedrine retention
in these volunteers are depicted schematically in Figure 3 .
Patient map pixels >2 .5 SD below data-base values were
defined as abnormal . These data were in turn displayed on a
separate polar map for each study, and the extent of the left
ventricle with abnormal blood flow/C- II hydroxyephedrine

























Absolute tissue C-11 hydroxyephedrine retention fraction .
Using these polar maps, three myocardial zones were de-
fined: zone 1, with abnormal rest flow and C-ll hydroxy-
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Figure 3. Maps of flow (left) and carbon (C)-I I hydroxy
ephedrine (HED) retention (right) in 14 volunteers
These !naps show regional tracer activity expressed as .
percent of regional maxima, demonstrating the regions
homogeneity of blood flow and C-1I hydroxyephedrin
retention in these subjects. ANT = anterior; INF
inferior; LAT = lateral; SEPT = septal .
ephedrine retention, representing infarcted tissue ; zone 2
with normal flow but decreased C-11 bydroxyephedrini
retention seen around zone I in I I patients, and zone 3, wit]
Figure 4. Patient example. A, Study fmn
a 73-year old woman with aborted suddei
death due to acute left circumflex occlu
sion treated with recombinant tissue-typ
plasminogen activator. Representative
short- and long-axis images of flow (left
and carbon (C)-I1 hydroxyephedrine re
tention (right) are from the study per
formed 7 days after infarction . Note the
small lateral wall flow abnormality with
much more extensive corresponding C-I
hydroxyephedrine abnormality . B, Pola
maps corresponding to the images in A
Top, Relative count distribution . Bottom
Maps where pixels >2 .5 SD outside the
normal data base range are shown in color
flow, 1% versus C-11 hydroxyephedrint
(HED) abnormality, 32% . C, Polar map:
of relative tracer distribution for the earl`
(top) and follow-up (bottom) studies . Flov
is at left, C-I I hydroxyephedrine at right
Observe the lack of change between the
two studies .
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normal flow and C-I f hydroxycpbedrine retention, repre-
senting remote myocardium . Corresponding myocardial re-
gions of interest were defined on the short-axis C-11 hydroxy-
ephedrine images as well as a blood pool region . Retention
fraction for C-l I hycroxyephedrine was estimated in each
region as
Retention fraction
Tissue counts 30 to 40
min after injection
fArterial input curve 0 to 40 min after injection
Additionally, because C-11 hydroxyephedrine retention
has been previously demonstrated in this laboratory to be
dependent on myocardial blood flow (6), we plotted regional
reduction in tissue counts for C-Il hydroxyephedrine and
flow expressed as a percent of the value in remote myocar-
dium for each patient . This was done to demonstrate reduc-
tion in retention beyond what would be expected on a tracer
delivery basis alone in regions with reduced blood flow at
rest .
Statistics. Data are expressed as mean value ± I SD .
Comparisons between the extent of abnormalities and be-
tween groups were made with the chi-square test . Differ-
ences in group means were compared using the Student t test
or analysis of variance, as appropriate . Differences over time
were compared by repeated measures analysis of variance .
Subsequent between-group comparisons were made by the
Scheffe F test. The relation between flow and C-I I hydroxy-
ephedrine retention was compared by linear regression using
a least-squares technique with calculation of the Pearson
correlation coefficient r and t test for significance of the slope
of the regression line .
Results
Patient characteristics. There were 13 men and 3 women,
with a mean age of 54 ± 11 years . Eleven patients had a Q
wave and five a non-Q wave infarction . The site of infarction
was anterior in eight, inferior in seven and lateral wall in one
patient. Fourteen patients had single-vessel and two had
double-vessel coronary artery disease at angiography .
An example of a patient study is depicted in Figure 4A.
This study was performed on a 73-year old woman with a
previous history of hypertension and chest pain with multi-
vessel coronary artery disease who was treated with intra-
venous rt-PA after she survived an episode of sudden death
associated with polymorphic ventricular tachycardia degen-
erating into ventricular fibrillation . An ECG during conva-
lescence showed lateral ST changes without new Q waves .
Coronary angiography revealed multive:,sel disease with a
tightly stenosed left circumflex artery . The initial predis-
charge study performed 7 days after the episode (Fig. 4A)
demonstrates a small lateral wall blood flow abnormality
with a correspondingly much larger C-11 hydroxyephedrine
abnormality. Figure 4B shows corresponding polar maps of
this patient study compared with the normal data base,
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. A, Extent of neuronal and flow abnormalities for early
studies (n = 16). Carbon (C)-l l hydroxyephedrine (HED) defects
were larger overall than the myocardial infarct size defined from
blood flow images
. This relation was strongest in non-Q wave
myocardial infarction (p = 0.008)
. LV = left ventricle . B, Same data
as in A but depicted as a scatterplot for individual patients
. All five
patients with non-Q wave myocardial infarction showee C-I1 hy-
droxyephedrine abnormality more extensive than that for flow (open
circles), as did six patients with Q wave infarction (closed circles) .
indicating that 1% of the blood flow map area is abnormal,
whereas 32% of the corresponding C-11 hydroxyepbedrne
map is abnormal, indicating the greater extent of the neuro-
nal injury versus blood flow abnormality in this patient with
a non-Q wave infarction in the left circumflex territory. The
early and 6-month follow-up polar maps for this patient (Fig.
4C) demonstrate no change .
Early studies . Extent of neuronal dysfunction . Polar map
extent of flow and C-11 hydroxyephedrine abnormalities are
depicted in Figure 5A for group data and in Figure 5B for
individual patients. For the whole group, C-11 hydroxy-
ephedrine abnormality was larger than for flow (31
15% vs . 17 ± 17% left ventricle, p < 0 .05)
. This finding was
greatest in cases of non-Q wave infarction (31 ± 11% vs .
3.5 ± 2.5% left ventricle, p = 0 .008)
. By contrast, studies in
1 l patients with Q wave infarction did not reveal statis :i^ally
significant differences when comparing extent of C-11 by-
droxyephedrine and flow defects (28 ± 17% vs . 21 ± 17% left
ventricle, p = NS).
Severity of neuronal dysfunction .
The absolute tissue
retention fraction for C-I1 hydroxyephedrine,
representing
the uptake and storage capacity of myocardial neurons
for
catecholamines, is represented ' .
Figure 6 for early studies .
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Figure 6. Absolute tissue retention fraction of carbon-I
I hydroxy-
ephedrine for early studies (n = 16) . Counts in each myocardial
region normalized to the arterial input function . Retention fraction
went from lowest in zone 1(infarct center), intermediate value in
zone 2 (surrounding zone I) and highest in zone 3 (remote) . *p =
0.0004.
There was a pattern of retention fraction being significantly
different in each defined myocardial region : lowest in zone 1
(0.037 ± 0.022''"'"), intermediate in zone 2 (0 .068 t
0.034-111) and highest in zone 3 (0.087 ± 0.041 -1"'), (p =
0.0004) .
Carbon-I1 hydroxyephedrine tissue uptake and retention
have been previously demonstrated to be dependent on
myocardial blood flow (6) . To demonstrate that decreased
tissue C-11 hydroxyephedrine retention in regions with
decreased rest flow were due to abnormal neuronal function
rather than simply reflecting any local reduction in tracer
delivery, we plotted regional reduction in tissue counts for
C-11 hydroxyephedrine and flow expressed as a percent of
the value for remote myocardium in each patient (Fig . 7) .
These data showed that C-l1 hydroxyephedrine retention
was related to tracer delivery in both zones 1(infarct) and 2
(peri-infarct), (r = 0 .87 and r == 0 .79, respectively) ; however,
in zone 1, C-11 hydroxyephedrine retention was reduced
more than flow (48 ± 18% vs. 67 ± 21% of the value in
remote myocardium, p = 0.0001), with milder reductions but
Figure 7 . Relation between tracer delivery and carbon (C)-11 hy-
droxyephedrine retention for short-term studies. Flow (stippled
bars) and carbon-11 hydroxyephedrine (solid bars) retention ex-
pressed as percent of counts in remote myocardium (zone 3) . Flow
is mildly reduced in zone 2 and further reduced in zone 1 . Although
C-1 l hydroxyephedrine retention is delivery dependent, this graph
demonstrates that in both zones, C-11 hydroxyephedrine retention
is reduced more than would be anticipated from the corresponding
reductions in blood flow, suggesting neuronal abnormality as the
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III
Figure 8. Extent of abnormalities : Early (stippled bars) versus
follow-up (solid bars) studies (n = 8) . In the group followed up at 8 ±
3 months (n = 8), neither carbon-I1 hydroxyephedrine nor flow
abnormalities changed extent significantly . *p = NS. LV = left
ventricle .
still following the same trend in zone 2 (68 ± 13% vs . 81 ±
13%, p = 0 .005) .
Follow-up studies. Extent ofnezironal dysfunction. Four
patients with a Q wave and four with a non-Q wave infarc-
tion underwent follow-up positron emission tomography
studies at 8 ± 3 months . No significant changes in the
myocardial distribution of the flow marker or C-11 hydroxy-
ephedrine were observed (Fig . 8). For flow, the extent of
abnormality was 10 ± 7 .3% versus 13 ± 6 .0% in early versus
follow-up study (p = NS) and for C-11 hydroxyephedrine,
31 ± 11% versus 34 t 15% left ventricle (p = NS),
respectively .
Severity of neuronal dysfunction . Tissue retention frac-
tion for C-Il hydroxyephedrine showed no significant
change at follow-up in any of the defined myocardial zones .
Early and follow-up retention fractions were 0 .047 ±
0.026-1'" versus 0.049 ± 0.028"" for zone 1, 0 .061 ± 0.032
versus 0.075 ± 0.034-11" for zone 2, and 0 .091 + 0.039
versus 0.11 ± 0.043
min
for zone 3, (p = NS for all zones,
early vs. follow-up, respectively) . There were no significant
differences in regional retention fraction for Q wave versus
non-Q wave infarction in the eight patients .
Discussion
Summary of findings . This imaging study using positron
emission tomogtuplly in pa nts given thrombolytic therapy
after acute myocardial infarction demonstrated sympathetic
neuronal injury as reflected in abnormal C-11 hydroxy-
ephedrine retention that exceeded the extent of tissue necro-
sis defined by rest blood flow abnormalities. The greatest
disparity between extent rf neuronal injury and blood flow
was observed in patients with non-Q wave infarction .
We also observed a greater absolute reduction of neuro-
nal tracer retention in the infarct center (zone 1) and inter-
mediate severity in tissue with normal rest flow adjacent to
the infarct center (zone 2), suggesting a varying degree of
neuronal damage within the infarct territory .
Follow-up studies at 8 months in the patients studied
showed no change in extent of C-11 hydroxyephedrine or





HYCROXYLPHEDRINE PET AFTER MYOCARDIAL INFARCTION
flow abnormalities, indicating persistent neuronal damage in
either the infarct center or adjacent pert-infarct segments
without scintigraphic evidence of reinnervation .
Previous studies using metaiodobenzylguanidine and
qualitative scintigraphic approaches have also demonstrated
this disparity between the extent of sympathetic neuronal
injury and blood flow abnormality after myocardial infarc-
tion (6,9,11) ; however, to our knowledge this is the first
investigation that includes follow-up studies to evaluate the
possible reversibility of neuronal abnormalities . In contrast
to single-photon emission computed tomography, positron
emission tomography allows the quantitative assessment of
severity of neuronal injury, taking advantage of the im-
proved imaging techt .ology this technique provides .
Animal experimental data. Previous studies in our and
other laboratories have explored the use of radiotracers to
investigate sympathetic neuronal injury in experimental
models. Using either induced acute myocardial ischemic
injury or phenol disruption of epicardial sympathetic nerves,
scintigraphic abnormalities with the related norepinephrine
analogues metaiodobenzylguanidine and fluorine-18 fluo-
rometaraminol have been correlated with reduced tissue
norepinephrine content and histochemical evidence of sym-
pathetic nerve disruption (8,9,21,22) .
Minardo et al . (15) correlated such scintigraphic abnor-
malities in a canine model of acute ischemic injury (induced
with either intracoronary latex injection or occlusion) with
electrophysiologic measurements . They found evidence of
denervation and denervation hypersensitivity distal to the
zone of injury in cases of transmural infarction with accom-
panying distal metaiodobenzylguanidine scintigraphic abnor-
malities . Our present findings in humans indicate evidence of
abnormal C-11 hydroxyephedrine retention not only distal to
the sites of infarction, but also lateral to these sites . One
major difference in the studies was that our patients all
received thrombolytic therapy and may reasonably be ex-
pected to have reperfused and salvaged myocardium . An-
other difference is that experimental infarction in the animals
required manipulation of the coronary artery, and distal
denervation due to epicardial nerve trunk damage associated
with this manipulation reported by other investigators
(22,23) cannot be completely excluded .
In experimental protocols perhaps more closely reflecting
events in the current patient population, this laboratory
previously reported findings using norepinephrine radioana-
logues in canine models of brief and more prolonged coro-
nary occlusion followed by reperfusion designed to repro-
duce conditions of 1) reversible ischemia and 2) more severe
myocardial injury, respectively . After relatively brief occlu-
sion and reperfusion, Schwaiger a al. (22) demonstrated
decreased sympathetic nerve terminal retention of fluorine-18
fluorometaraminol in regions without myocardial necrosis,
showing the sensitivity of the sympathetic nerve terminals to
even brief periods of reversible ischemia. In a separate study
using a longer balloon occlusion followed by reperfusion,




lion in regional blood flow (measured by microsphere tech-
nique), the pattern of myocardial injury (assessed by tri-
phenyltetrazolium staining) and the severity of neuronal
injury (as measured by C-11 hydroxyephedrine retention
fraction). These investigators showed the most severe reduc-
tion in C-11 hydroxyephedrine retention fraction in necrotic
tissue but also demonstrated reduced retention fraction in
reperfused salvaged myocardium without evidence of necro-
sis. Reductions in tracer uptake were paralleled by rft-uc-
tions in assayed tissue norepinephrine content . The severity
of neuronal injury was related to the seventy of reduction in
regional myocardial blood flow during ischemia and was not
related to reperfusion blood flow . 'this experimental obser-
vation may explain the large disparity between flow and C-f I
hydroxyephedrine abnormalities in patients with non-Q
wave infarction . In these patients, the C-11 hydroxyephed-
rine abnormalities may reflect the area of risk during the
acute ischemia, whereas the flow pattern is more related to
the salvage after reperfusion, with irreversible tissue injury
restricted to suburdocardial layers of the myocardium .
The findings of these two experimental studies are in
keeping with data from isolated rat heart experiments (24) .
The latter demonstrated that brief ischemic periods resulted
in early functional changes in the presynaptic sympathetic
neuron ; but as ischemic time increased, irreversible struc-
tural changes occurred, usually at approximately 2 to 4 h,
which is similar to the time window to expected reperfusion
from symptom onset in the patients in the present study (25) .
C-11 hydroxyephedrine as a tracer of the sympathetic
nerve terminal. To interpret the relation between C-11 hy-
droxyephedrine scintigraphic patterns and pathophysiologic
alterations within the nerve terminal, it is necessary to take
into account the tracer behavior of C-11 hydroxyephedrine .
After injection, C-11 hydroxyephedrine rapidly enters the
nerve terminal via the uptake-1 rarr'.:,r for catecholamines . It
is subsequently incorporated ii .o :,torage vesicles available
for neuronal release into the synaptic cleft as well as
reuptake into the nerve terminal.
Thus, measurements of C-11 hydroxyephedrine retention
in tissue represent the combined p •r.=cesses of norepineph-
rine uptake, storage and continuous release within the heart .
Retention therefore reflects both nerve terminal numbers in
the heart as well as their functional integrity . Although C-11
hydroxyephedrine cannot differentiate between the pro-
cesses of uptake and storage, the use of combined tracers
with different kinetic properties, such as threo-meta-C-11
hydroxyephedrine (26) and C-11 epinine (27), currently
under evaluation at our institution, may in the future allow
differentiation between uptake and storage .
Carbon-11 hydroxyephedrine is in competition with en-
dogenous norepinephrine for both uptake and storage in the
heart. DeGrado et al .
(3), in this laboratory, demonstrated in
the isolated rat heart that myocardial C-t
1 hydroxyephed-
rine retention is affected by the level of circulating norepi-
nephrine. Plasma norepinephrine values obtained in 12 of
our patients did not show any relation to retention fraction .
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This probably reflects the limitations in extrapolating from
plasma to synaptic norepinephrine concentration, which
cannot be measured in the human heart .
Another important factor in assessing C-11 hydroxy-
ephedrine retention is regional myocardial blood flow . We
also examined regional blood flow and C-11 hydrtixyephed-
rine retention within the infarct and peri-infarct regions,
expressed as the percent of the value in the remote myocar-
dium. In both regions, C-11 hydroxyephedrine retention was
decreased significantly more than flow, suggesting neuronal
injury rather than simply reduced tracer delivery as the
cause for the observed abnormalities .
Time course of changes in neuronal function . Evidence for
partial reinnervatlon after experimental transmural myocar-
dial infarction in dogs has been found at 14 weeks using
metaiodobenzylghanidine scintigraphy with neuroelectro-
physiologic correlation (15) ; however, in the same study,
persistent denervation hypersensitivity was also observed
concurrently . Histologic evidence for partial Schwann cell
sad axonal regeneration in the infarcted territory >4 weeks
after experimental myocardial infarction in rats has also
been reported (28) . In the present study, we observed no
change in the extent or severity of C-11 hydroxyephedrine
scintigraphic abnormalities at 8-month patient follow-up.
One potential confounding factor may have been the occur-
rence of repetitive ischemia within the regions o . salvaged
myocardium because only two of the eight patients followed
up underwent revascularization before restudy . A more
likely explanation is that recovery from neuronal injury
either does not occur or is of a degree that is undetectable
using C-11 hydroxyephedrine scintigraphy with current
positron emission tomography technology .
Conclusions. Positron emission tomography in combina-
tion with the norepinephrine analogue C-11 hydroxyephed-
rine allows quantitative assessment of the pattern of isch-
emic neuronal injury in humans . We found evidence
indicating neuronal injury more extensive than the extent of
myocardial necrosis defined by rest blood flow imaging,
confirming previous experimental observations . This finding
may reflect greater sensitivity of neurons to ischemia com-
pared with myocytes. The persistent pattern of neuronal
abnormalities exceeding the infarct territory suggests little
"reinnervation" of ischemically injured myocardium within
tho period of observation. Future correlation of this scinti-
graphic finding with regional electrophysiologic properties is
required to define the physiologic and prognostic signifi-
cance of regional "denervation" of myocardium in patients
with myocardial infarction .
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